299 related articles for article (PubMed ID: 7872783)
1. Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid.
Bhattacharyya DK; Lecomte M; Dunn J; Morgans DJ; Smith WL
Arch Biochem Biophys; 1995 Feb; 317(1):19-24. PubMed ID: 7872783
[TBL] [Abstract][Full Text] [Related]
2. Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2.
Xiao G; Tsai AL; Palmer G; Boyar WC; Marshall PJ; Kulmacz RJ
Biochemistry; 1997 Feb; 36(7):1836-45. PubMed ID: 9048568
[TBL] [Abstract][Full Text] [Related]
3. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin.
Lecomte M; Laneuville O; Ji C; DeWitt DL; Smith WL
J Biol Chem; 1994 May; 269(18):13207-15. PubMed ID: 8175750
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
Chulada PC; Langenbach R
J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of prostaglandin H2 synthases by salicylate is dependent on the oxidative state of the enzymes.
Aronoff DM; Boutaud O; Marnett LJ; Oates JA
J Pharmacol Exp Ther; 2003 Feb; 304(2):589-95. PubMed ID: 12538810
[TBL] [Abstract][Full Text] [Related]
6. The role of arginine 120 of human prostaglandin endoperoxide H synthase-2 in the interaction with fatty acid substrates and inhibitors.
Rieke CJ; Mulichak AM; Garavito RM; Smith WL
J Biol Chem; 1999 Jun; 274(24):17109-14. PubMed ID: 10358065
[TBL] [Abstract][Full Text] [Related]
7. Comparison of prostaglandin H synthase isoform structures using limited proteolytic digestion.
Guo Q; Chang S; Diekman L; Xiao G; Kulmacz RJ
Arch Biochem Biophys; 1997 Aug; 344(1):150-8. PubMed ID: 9244392
[TBL] [Abstract][Full Text] [Related]
8. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
[TBL] [Abstract][Full Text] [Related]
9. Mutation of serine-516 in human prostaglandin G/H synthase-2 to methionine or aspirin acetylation of this residue stimulates 15-R-HETE synthesis.
Mancini JA; O'Neill GP; Bayly C; Vickers PJ
FEBS Lett; 1994 Mar; 342(1):33-7. PubMed ID: 8143845
[TBL] [Abstract][Full Text] [Related]
10. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biochemical evaluation of N-substituted maleimides as inhibitors of prostaglandin endoperoxide synthases.
Kalgutkar AS; Crews BC; Marnett LJ
J Med Chem; 1996 Apr; 39(8):1692-703. PubMed ID: 8648609
[TBL] [Abstract][Full Text] [Related]
12. Existence of endogenous inhibitor(s) of prostaglandin endoperoxide H synthase activities in murine NIH3T3 fibroblasts.
Shitashige M; Morita I; Murota S
Prostaglandins Leukot Essent Fatty Acids; 1999 Aug; 61(2):97-103. PubMed ID: 10509864
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for the inhibition of prostanoid biosynthesis by nonsteroidal anti-inflammatory agents.
Smith WL; DeWitt DL; Shimokawa T; Kraemer SA; Meade EA
Stroke; 1990 Dec; 21(12 Suppl):IV24-8. PubMed ID: 2175460
[TBL] [Abstract][Full Text] [Related]
14. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs.
Smith WL; DeWitt DL
Semin Nephrol; 1995 May; 15(3):179-94. PubMed ID: 7631045
[TBL] [Abstract][Full Text] [Related]
15. Expression of the murine prostaglandin (PGH) synthase-1 and PGH synthase-2 isozymes in cos-1 cells.
Meade EA; Smith WL; DeWitt DL
J Lipid Mediat; 1993; 6(1-3):119-29. PubMed ID: 8357978
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2.
Smith WL; Meade EA; DeWitt DL
Ann N Y Acad Sci; 1994 Apr; 714():136-42. PubMed ID: 8017762
[TBL] [Abstract][Full Text] [Related]
17. C-terminal Ser/Pro-Thr-Glu-Leu tetrapeptides of prostaglandin endoperoxide H synthases-1 and -2 target the enzymes to the endoplasmic reticulum.
Song I; Smith WL
Arch Biochem Biophys; 1996 Oct; 334(1):67-72. PubMed ID: 8837740
[TBL] [Abstract][Full Text] [Related]
18. Altered sensitivity of aspirin-acetylated prostaglandin G/H synthase-2 to inhibition by nonsteroidal anti-inflammatory drugs.
Mancini JA; Vickers PJ; O'Neill GP; Boily C; Falgueyret JP; Riendeau D
Mol Pharmacol; 1997 Jan; 51(1):52-60. PubMed ID: 9016346
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
O'Neill GP; Mancini JA; Kargman S; Yergey J; Kwan MY; Falgueyret JP; Abramovitz M; Kennedy BP; Ouellet M; Cromlish W
Mol Pharmacol; 1994 Feb; 45(2):245-54. PubMed ID: 8114674
[TBL] [Abstract][Full Text] [Related]
20. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
Kalgutkar AS; Kozak KR; Crews BC; Hochgesang GP; Marnett LJ
J Med Chem; 1998 Nov; 41(24):4800-18. PubMed ID: 9822550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
